Percutaneous Peritoneal Dialysis Catheter Insertion (PREDICT)

Peritoneal dialysis (PD) is the most frequent modality of home dialysis for patients with kidney failure. Most PD catheters are placed using a laparoscopic technique. This approach requires the availability of a qualified surgeon, time in the operating theater and general anaesthesia for the patient. Thus, the laparoscopic technique is less suitable for patients with severe heart failure or multimorbidity where general anaesthesia is not possible. PD catheters can also be inserted using a percutaneous strategy using a modified Seldinger technique. This strategy can be performed bedside under local anaesthesia, by the nephrologist, radiologist, a surgeon, physician assistant or qualified nurse. The availability of the percutaneous implantation strategy of a PD catheter in a nephrology center may accomodate more patients to receive a PD catheter insertion, including those who have a contraindication to general anaesthesia or need urgent PD. The PREDICT project aims to increase knowledge and competencies on percutaneous PD catheter insertions by training centers for this technique. By establisching a prospective registry, the outcomes of percutaneously inserted PD catheters, both in experienced and newly trained centers, will be assessed.

NCT Number	NCT06065982
Lead Sponsor	Universitair Ziekenhuis Brussel Collaborators: UMC Utrecht, Leiden University Medical Center, Bravis Hospital, Erasme University Hospital, University Hospital, Antwerp, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, az Glorieux, Imelda Hospital, Bonheiden, Centre Hospitalier Régional de la Citadelle, Rijnstate Hospital, Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC), HagaZiekenhuis, Bernhoven Hospital, Isala, Deventer Ziekenhuis, Medisch Centrum Leeuwarden, OLVG, Centro Hospitalar Universitario do Algarve, University Medical Centre Ljubljana
Conditions	End-stage Kidney Disease
Enrollment	500 participants
Start Date	2023-06-23
Primary Completion	2026-06-23 (estimated)
Study Completion	2027-06-23 (estimated)
Updated on ClinicalTrials.gov	2023-10-04